Depression, Anxiety, and Risk of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Longitudinal Study
- 13 April 2024
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (3) , e750-e756
Abstract
Context Patients with polycystic ovary syndrome (PCOS) are at high risk of depression, anxiety, and metabolic syndrome (MetSyn), a key predictor of cardiovascular disease. The impact of depression and/or anxiety on MetSyn is unknown in this population. Objective To compare the risk of developing MetSyn in patients with PCOS with and without a history of depression and/or anxiety. Methods Retrospective longitudinal cohort study (2008-2022) with median follow-up of 7 years at a tertiary care ambulatory practice. Patients with hyperandrogenic PCOS and at least 2 evaluations for MetSyn ≥3 years apart (n = 321) were included. The primary outcome was risk of developing MetSyn. We hypothesized that this risk would be higher with a history of depression and/or anxiety. Results At the first visit, 33.0% had a history of depression and/or anxiety, with a third prescribed antidepressants or anxiolytics. Depression and/or anxiety increased risk of developing MetSyn during the study period (adjusted hazard ratio [aHR] 1.45, 95% CI 1.02-2.06, P = .04) with an incidence of MetSyn of 75.3 compared with 47.6 cases per 100 person-years among those without (P = .002). This was primarily driven by depression (aHR 1.56, 95% CI 1.10-2.20, P = .01). Conclusion Patients with PCOS and depression and/or anxiety have a high risk of developing MetSyn, with a stronger association between depression and MetSyn. Our findings highlight the urgent need for guideline-directed screening for depression and anxiety at time of diagnosis of PCOS as well as screening at subsequent visits to facilitate risk stratification for metabolic monitoring and early intervention in this high-risk group.Keywords
This publication has 28 references indexed in Scilit:
- Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and AnxietyBiological Psychiatry, 2019
- Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal studyFertility and Sterility, 2019
- Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trialFertility and Sterility, 2018
- Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional studyAmerican Journal of Obstetrics and Gynecology, 2017
- Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOSFertility and Sterility, 2014
- The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adultsGeneral Hospital Psychiatry, 2008
- Associations Between Anxiety, Depression, and the Metabolic SyndromeBiological Psychiatry, 2007
- Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteriaFertility and Sterility, 2007
- Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-AnalysisThe American Journal of Medicine, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004